IL93599A0 - Kit and/or composition for the prevention or treatment of aids - Google Patents

Kit and/or composition for the prevention or treatment of aids

Info

Publication number
IL93599A0
IL93599A0 IL93599A IL9359990A IL93599A0 IL 93599 A0 IL93599 A0 IL 93599A0 IL 93599 A IL93599 A IL 93599A IL 9359990 A IL9359990 A IL 9359990A IL 93599 A0 IL93599 A0 IL 93599A0
Authority
IL
Israel
Prior art keywords
prevention
treatment
aids
kit
composition
Prior art date
Application number
IL93599A
Other languages
English (en)
Original Assignee
Microgenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenesys Inc filed Critical Microgenesys Inc
Publication of IL93599A0 publication Critical patent/IL93599A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
IL93599A 1989-03-03 1990-03-01 Kit and/or composition for the prevention or treatment of aids IL93599A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31827289A 1989-03-03 1989-03-03

Publications (1)

Publication Number Publication Date
IL93599A0 true IL93599A0 (en) 1990-12-23

Family

ID=23237447

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93599A IL93599A0 (en) 1989-03-03 1990-03-01 Kit and/or composition for the prevention or treatment of aids

Country Status (8)

Country Link
EP (1) EP0385909B1 (de)
JP (1) JPH03163027A (de)
AT (1) ATE108335T1 (de)
AU (1) AU635001B2 (de)
CA (1) CA2011299A1 (de)
DE (1) DE69010523D1 (de)
DK (1) DK0385909T3 (de)
IL (1) IL93599A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
AU648041B2 (en) * 1989-08-23 1994-04-14 General Hospital Corporation, The Non-human primate CD4 polypeptides, fusions thereof, DNA encoding, and uses thereof
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
DK0636173T3 (da) * 1991-05-31 1999-05-31 Genentech Inc Behandling af HIV associeret immunthrombocytopenisk purpura
AU680916B2 (en) 1993-05-07 1997-08-14 Biomerieux, Inc. HIV immunogenic complexes
EP0893507A1 (de) 1997-07-25 1999-01-27 Institut Gustave Roussy Verwendung von MHC Klass II Liganden (CD4 und LAG-3) als Adjuvanz für Impfungen und von LAG-3 in der Behandlung von Krebs
KR20200003915A (ko) * 2017-05-10 2020-01-10 알바후나 테라퓨틱스, 에스.엘. 높은 이중 ＨＩＶ 항바이러스 활성과 면역조절 활성을 갖는 Ｆｃ-융합 단백질 유도체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US344304A (en) * 1886-06-22 Spindle-support
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
IE872748L (en) * 1986-10-16 1988-04-16 Arjomari Europ Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
JPS63258575A (ja) * 1986-12-15 1988-10-26 レプリゲン　コーポレーション 昆虫細胞中でつくられる組換えｈｉｖエンベロープタンパク
AU609447B2 (en) * 1987-02-19 1991-05-02 Nissin Shokuhin Kabushiki Kaisha Methods and materials for hiv detection and therapy
EP0287226A1 (de) * 1987-03-23 1988-10-19 Hiver Limited Impfstoff

Also Published As

Publication number Publication date
AU635001B2 (en) 1993-03-11
CA2011299A1 (en) 1990-09-03
AU5061090A (en) 1990-11-01
EP0385909A3 (de) 1991-04-10
DE69010523D1 (de) 1994-08-18
DK0385909T3 (da) 1994-08-15
EP0385909B1 (de) 1994-07-13
JPH03163027A (ja) 1991-07-15
ATE108335T1 (de) 1994-07-15
EP0385909A2 (de) 1990-09-05

Similar Documents

Publication Publication Date Title
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
LU90935I2 (en) Azopt-brinzolamide
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
LU91433I2 (fr) "Tenofovir disoproxil et les sels, en particulier le fumarate, hydrates, tautomers et solvates en combination avec l'emtricitabine et l'efavirenz (ATRIPLA)
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
AU2843689A (en) 2-(2-hydroxy-3-phenoxypropylamino) ethylphenoxymethyl compounds
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
KR0156686B1 (en) Pharmaceutical composition comprising aryl-substituted rhodanine derivatives
GR3006815T3 (de)
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
WO1991015512A3 (en) Hiv envelope polypeptides
EP0306219A3 (de) HIV-Proteine und Peptide zur Verwendung in Diagnose, Prophylaxe und Therapie von AIDS
IL93599A0 (en) Kit and/or composition for the prevention or treatment of aids
CA2089853A1 (fr) Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses
AU7125991A (en) Novel antiulcer substance
HU886266D0 (en) Process for the production of medical preparations containing buspiron and its salts for peroral use
NZ231320A (en) Aqueous oral preparations of diclofenac
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
GR3014952T3 (en) Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human.
EP0379295A3 (de) Antitryptase-Antikörper und diese enthaltende Zusammensetzung zur Behandlung von AIDS
AU696629B2 (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
CA2014884A1 (en) 5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of aids